If every juggaloo bought 1,000 shares we could get this above $3 again!
Then why would aldoxorubicin get fda approval? I don't see any evidence to support the theory that aldoxorubicin is more effective than doxorubicin.
Will it stay above $1?
Or will it just get delisted and drop to a nickel on the pink sheets?
When this inevitably drops under a buck soon?
Nothing would surprise me.
Earnings will be a huge miss and another bloodbath. Then you'll see why $2.75 was actually a good selling price.
Only three months after Oppenheimer put a $10 price target on the stock. Seems like typical wall street shenanigans.